PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, USA.\', \'Aetion, Inc., New York, New York, USA.\', \'Department of Epidemiology, Columbia University, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cpt.2185
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33529354
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
?:title
  • Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33529354>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33529354>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all